MedPath
NMPA Approval

Recaticimab for Injection

国药准字S20250002

January 8, 2025

Drug Information

注射用瑞卡西单抗

艾心安

注射剂

150 mg/瓶

生物制品

January 8, 2025

Company Information

Applicant Company

广州市黄埔区康耀南路55号

Manufacturing Company

中国(江苏)自由贸易试验区苏州片区苏州工业园区凤里街350号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用瑞卡西单抗 - NMPA 批准文号 | MedPath